ArticleScientific reports2017

Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease.

Isabel Gameiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.